Safety & Tolerability of 8mg ASM8 in moderate to severe asthmatics

• Research type

  Research Study

• Full title

  A phase II, multi-centre, single blind study to evaluate the safety, tolerability and explore the efficacy of 8.0 mg ASM8 inhaled daily for 14 days in adult subjects with moderate to severe asthma

• IRAS ID

  74735

• Contact name

  Tim Harrison

• Contact email

  tim.harrison@nottingham.ac.uk

• Sponsor organisation

  Pharmaxis Ltd

• Eudract number

  2011-000126-30

• ISRCTN Number

  N/A

• Research summary

  Research Summmary not published at request of researcher

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  11/NE/0093

• Date of REC Opinion

  7 Jun 2011

• REC opinion

  Further Information Favourable Opinion